Apolipoprotein E genotypes associated with Alzheimer disease and concomitant stroke

J Stroke Cerebrovasc Dis. 2014 Apr;23(4):681-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.06.018. Epub 2013 Jul 18.

Abstract

Background: The ɛ4 allele of the apolipoprotein E (APOE) gene is a well-characterized genetic risk factor for Alzheimer disease (AD). The association between stroke and a higher risk for AD has also been reported. Our study sought to determine the relationship between the APOE gene and AD and the comorbid risk of stroke.

Methods: The subjects of this study consisted of 48 patients with AD and 48 members of a control group. All subjects were genotyped for APOE.

Results: The results clearly show a significant increased risk of AD in carriers of the APOE ε3/ε4 genotype (P = .003, odds ratio [OR] = 4.1) or ε4 allele (P = .001, OR = 4.2). The risk for stroke in AD patients was also increased for carriers of the APOE ε3/ε4 genotype (P = .02, OR = 9.0) and for carriers of the APOE ε4 allele (P = .004, OR = 5.5).

Conclusions: The present study is the first to establish a relationship between APOE ε4 and concomitant AD and stroke in the Tunisian population.

Keywords: Alzheimer disease; Apolipoprotein E; genotyping; risk factor; stroke.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / complications*
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics*
  • Apolipoprotein E3 / genetics
  • Apolipoprotein E4 / genetics
  • Apolipoproteins E / genetics*
  • Case-Control Studies
  • DNA / genetics
  • Female
  • Genotype
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Risk Factors
  • Stroke / complications*
  • Stroke / epidemiology
  • Stroke / genetics*
  • Tunisia / epidemiology

Substances

  • Apolipoprotein E3
  • Apolipoprotein E4
  • Apolipoproteins E
  • DNA